What is TMLabs? The R&D Innovation Engine Powering Predictive Intelligence in Life Sciences TMLabs is the...
TMLabs Blogs
Top 8 Governance Considerations for AI in Pharma
AI Governance in Pharma: Essential Considerations for Responsible Innovation As Artificial Intelligence (AI) continues...
GLP-1s in India: A New Frontier in Affordable Weight Loss and Diabetes Care
The Patent Cliff That Changed Everything Within days of the patent expiry, Indian pharmaceutical companies launched a...
What if Message Resonance Score™ Became the Most Valuable Metric in Pharma Marketing?
When One Message Does Not Fit All Advances in data science and intelligent analytics are accelerating the shift toward...
The Expanding Horizon of GLP-1 Therapies: Beyond Diabetes
Glucagon-like peptide-1 (GLP-1) receptor agonists have long been established as effective treatments for type 2...
The Ethics of Health Data: Turning Patient Conversations into Intelligence the World Can Trust
Ethics in Health Data: Building Intelligence the World Can Trust Artificial Intelligence is rapidly becoming embedded...
Understanding Gene Therapy: A Groundbreaking Approach
A New Approach to Treating Rare Genetic Diseases Traditional treatments for rare genetic diseases often focus on...
From Personas to Proof: Building HCP Personas from Real-Life Voice and Measuring What Actually Resonates
Most HCP Personas Align Teams - Few Predict Behavior In the pharmaceutical industry, Healthcare Professional (HCP)...
Why the Message Resonance Score™ Matters for Med Comms and Pharma
In Life Sciences, messaging is strategic. For Med Comms Agencies, the ability to prove that strategy is landing as...
How the Message Resonance Score™ works?
What is the Message Resonance Score™? The Message Resonance Score™ evaluates alignment between strategic messaging and...
What Is the Message Resonance Score™?
Talking Medicines transforms unstructured, real-life data into actionable intelligence. By combining Advanced Data...
What Does Consumerism in Pharma Actually Mean?
At Talking Medicines, we are increasingly asked about the evolving role of patients in the pharmaceutical landscape...





















